Diet Modification Clinical Trial
— CWWOfficial title:
Comparison of Two Diet and Exercise Approaches on Weight Loss and Health Outcomes in Obese Women
Verified date | April 2020 |
Source | Texas A&M University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine whether following a Curves high protein/low fat diet (30% carbohydrate, 45% protein, 25% fat) for 30-days several times during 16 weeks of participating in the Curves fitness program promotes stepwise reductions in body weight, improvements in body composition and/or improvements in markers of fitness and health better than following the Weight Watchers Momentum Program for the same time period.
Status | Completed |
Enrollment | 120 |
Est. completion date | March 22, 2012 |
Est. primary completion date | March 22, 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Participant is female - Participant is between the ages of 18 and 45 - Participant is sedentary and overweight (BMI > 27) Exclusion Criteria: - Participant has any metabolic disorder including known electrolyte abnormalities, heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; - Participant has a history of hypertension, hepatorenal, musculoskeletal, autoimmune or neurological disease; - Participant is taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive or androgenic medications; - Participant has been pregnant or lactating within the past 12 months or are planning to become pregnant during the next 12 months; - Participant is involved in a planned exercise program (> 30 min./d. 3 d./wk.) within 3 - 6 months prior to the start of the study; - Participant has taken any weight loss medications and/or dietary supplements that may affect muscle mass or body weight during the three month time period prior to beginning the study; - Participant has a recent history of weight change (+/- 7 lbs. within the last 3 months). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Texas A&M University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Composition: Body Weight | Changes in body weight (lbs. body weight) obtained via digital scale and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Primary | Body Composition: Fat Mass | Changes in body composition (lbs. fat mass) obtained via Dual-Energy X-Ray Absorptiometry (DXA) and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Primary | Body Composition: Lean Mass | Changes in body composition (lbs. lean mass) obtained via DXA and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Primary | Body Composition: Percent Body Fat | Changes in body composition (% body fat) obtained via DXA and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Primary | Energy Homeostasis: Resting Energy Expenditure (REE) | Changes in REE obtained via metabolic cart and expressed in absolute (kcal/d) and relative terms (kcals/kg/d) and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Muscular Strength: 1 Repetition Maximum (1 RM) Bench Press | Changes in bench press 1 Repetition Maximum (1RM) obtained from a bench press test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Muscular Strength: 1 Repetition Maximum (1 RM) Leg Press | Changes in leg press 1RM obtained from a leg press test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Muscular Endurance: 80% of 1 Repetition Maximum (1 RM) Bench Press Endurance Test | Changes in total repetitions at 80% of 1RM obtained from a bench press test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Muscular Endurance: 80% of 1 Repetition Maximum (1 RM) Leg Press Endurance Test | Changes in total repetitions at 80% of 1RM obtained from a leg press test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Lipid Panel: Cholesterol | Changes in cholesterol obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Lipid Panel: HDL Cholesterol | Changes in HDL cholesterol obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Lipid Panel: LDL Cholesterol | Changes in LDL cholesterol obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Lipid Panel: Triglycerides | Changes in triglycerides obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Lipid Panel: Cholesterol:HDL Ratio | Changes in cholesterol to HDL cholesterol ratio obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Comprehensive Metabolic Panel (CMP): Glucose | Changes in glucose obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Hormones: Insulin | Changes in insulin obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Hormones: Leptin | Changes in leptin obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Homeostatic Model Assessment of Insulin Resistance (HOMA-IR): Homeostatic Model Assessment of Insulin Resistance | Changes in HOMA-IR obtained via venous blood draws and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Hemodynamic Variable: Resting Heart Rate (HR) | Changes in resting heart rate (HR) obtained via a blood pressure meter and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Hemodynamic Variable: Resting Systolic Blood Pressure (SBP) | Changes in resting systolic blood pressure (SBP) obtained via a blood pressure meter and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Hemodynamic Variable: Resting Diastolic Blood Pressure (SBP) | Changes in resting diastolic blood pressure (DBP) obtained via a blood pressure meter and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Anthropometric Measures: Waist Circumference | Changes in waist circumference obtained via tape measure and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Anthropometric Measures: Hip Circumference | Changes in hip circumference obtained via tape measure and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Anthropometric Measures: Waist to Hip Ratio | Changes in the ratio of waist to hip (waist/hip circumference) analyzed with related anthropometric outcome measures via General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Exercise Capacity: Peak Exercise Capacity (VO2) | Changes in exercise capacity (VO2 max) obtained via a treadmill test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Exercise Capacity: Time to Peak Exercise Capacity (time to peak VO2) | Changes in exercise capacity (time to peak VO2 max) obtained via a treadmill test and analyzed by General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 16 weeks | |
Secondary | Dietary Energy Intake: Total Caloric Intake (kcals/d) | Changes in caloric/energy intake (kcals/d) analyzed with related energy intake outcome measures via General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Dietary Energy Intake: Carbohydrate | Changes in dietary carbohydrate intake (g/d and g/kg/d) analyzed with related energy intake outcome measures via General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Dietary Energy Intake: Fat | Changes in dietary fat intake (g/d and g/kg/d) analyzed with related energy intake outcome measures via General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks | |
Secondary | Dietary Energy Intake: Protein | Changes in dietary protein intake (g/d and g/kg/d) analyzed with related energy intake outcome measures via General Linear Model multivariate and univariate analyses with repeated measures and mean change from baseline with 95% confidence intervals (CI's) | Measured prior to supplementation (Pre), and after 4, 6, 10, 12 and 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03700736 -
The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT02047136 -
Dietary Treatment for Chronic Urticaria
|
N/A | |
Active, not recruiting |
NCT05544461 -
Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students
|
N/A | |
Completed |
NCT03290118 -
The Efficacy of Front-of-package Labelling Schemes: an Experimental Study
|
N/A | |
Suspended |
NCT04124016 -
Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites: "Metanols"
|
N/A | |
Completed |
NCT03457688 -
Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children
|
N/A | |
Completed |
NCT03241355 -
Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children
|
N/A | |
Recruiting |
NCT04616482 -
Therapeutic Nutrition With Technology in Primary Care
|
||
Recruiting |
NCT04401605 -
Fermented Food-Supplemented Diet in Ulcerative Colitis
|
N/A | |
Completed |
NCT03697317 -
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
|
N/A | |
Completed |
NCT03748056 -
Targeted Food Incentives to Improve Diet Quality and Health Among Adults
|
N/A | |
Not yet recruiting |
NCT03657316 -
Impact of School Based Education Program
|
N/A | |
Completed |
NCT03934476 -
The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes
|
N/A | |
Completed |
NCT03129581 -
Metabolic Impact of Time Restricted Feeding
|
N/A | |
Completed |
NCT03255603 -
Gastrointestinal Assessment of Three Novel RS4
|
N/A | |
Completed |
NCT03716479 -
Gum Acacia and Blood Glucose
|
N/A |